(Q37745678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Susanne Krüger Kjaer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

Paolo Bonanni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Nina B Latham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Paul-Henri Lambert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Keith Reisinger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Richard M Haupt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

6 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

4719-4730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20451636%20AND%20SRC:MED&resulttype=core&format=json

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

A five‐year evaluation of reports of overdose with indinavir sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Vaccine-induced pathogen strain replacement: what are the mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

7 January 2021

HPV infection in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Epidemiology and costs associated with genital warts in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070

Defining a strategy to evaluate cervical cancer prevention and early detection in the era of HPV vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.070